Physician profile
John Andrew Brown
NPI 1306887088
$258,297.70
in general payments reported to CMS, 2019-2025
15 companies · $76K in 2025
The $76K reported for 2025 was more than what 96% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,044 · 2020: $3,837 · 2021: $24K · 2022: $52K · 2023: $51K · 2024: $46K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $136K · Travel and Lodging: $21K · Royalty Or License: $9,356 · Food and Beverage: $5,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $135,648.93 |
| Travel and Lodging | $21,312.31 |
| Royalty Or License | $9,356.17 |
| Food and Beverage | $5,596.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $202,697.69 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Catalyst Orthoscience | $37,097.87 | 2020-2025 | Catalyst Fracture Shoulder System, Catalyst Total Csr, Catalyst Csr Shoulder System |
| Wright Medical Technology, INC. | $8,482.97 | 2019-2020 | |
| Fx Shoulder Solutions, INC | $3,684.66 | 2019-2021 | |
| Arthrex, INC. | $2,909.97 | 2020-2023 | |
| Impactortho, INC. | $2,346.25 | 2021-2025 | |
| Depuy Synthes Sales INC. | $323.31 | 2019-2020 | |
| Exactech, INC. | $175.00 | 2024 | |
| Miach Orthopaedics, INC. | $157.82 | 2023 | |
| Smith+Nephew, INC. | $109.59 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Firstpass, Healicoil |
| Zimmer Biomet Holdings, INC. | $107.33 | 2019-2025 | Affixus |
| Bioventus LLC | $82.68 | 2019-2020 | |
| Linvatec Corporation | $55.38 | 2019-2020 | |
| Biocomposites INC | $49.69 | 2019 | |
| Vericel Corporation | $17.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$489,296.73 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.